We are excited to announce that promising results from an international, first-in-human clinical trial showed that the ViaCyte #stemcell derived therapy can produce insulin in people with #T1D!
The results are published in Cell Stem Cell and Cell Reports Medicine. To learn more about the papers, visit https://bit.ly/3piVq1G
